Geoff McDonough, Generation Bio CEO
Hopes for non-viral gene therapy take a blow as Generation Bio announces significant setback
Last year, during the height of the biotech IPO boom, Generation Bio raised $230 million on a swing-for-the-fences approach to gene therapy.
Launched out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
